Plasma metabolomics in spinal tuberculosis patients and healthy controls
Description
This study aimed to conduct a non-targeted metabolomic analysis of plasma from patients with spinal tuberculosis (STB) to systematically elucidate the metabolomic alterations associated with STB. From January 2020 to January 2022, 30 patients with spinal tuberculosis (STBs) clinically diagnosed at the General Hospital of Ningxia Medical University and 30 age- and sex-matched healthy controls (HCs) were selected for this study. Using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS) based metabolomics, we analyzed the metabolic profiles of 60 plasma samples.
Files
Categories
Funding
Key Research and Development Program of Ningxia
2022BEG03099
National Natural Science Foundation of China
81860395
National Natural Science Foundation of China
82260436
National College Students Innovation and Entrepreneurship Training Program
202210752008